Effect of multiple pharmacy use on medication adherence and drug-drug interactions in older adults with medicare part D

Journal of the American Geriatrics Society

Volumn 62, Issue 2, 2014, Pages 244-252

  Marcum, Zachary A ^a   Driessen, Julia ^b   Thorpe, Carolyn T ^c,d   Gellad, Walid F ^a,d,e   Donohue, Julie M ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e RAND CORPORATION   (United States)

Author keywords

drug interactions; Medicare; medication adherence; pharmacy

Indexed keywords

DRUG INTERACTIONS; MEDICARE; MEDICATION ADHERENCE; PHARMACY;

AGED; CROSS-SECTIONAL STUDIES; DRUG INTERACTIONS; FEMALE; HUMANS; MALE; MEDICARE PART D; MEDICATION ADHERENCE; PHARMACEUTICAL SERVICES; PROPENSITY SCORE; RETROSPECTIVE STUDIES; TIME FACTORS; UNITED STATES;

EID: 84894065248     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.12645     Document Type: Article

References (30)

1. Qato DM, Alexander GC, Conti RM, et al. Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States. JAMA 2008; 300: 2867-2878.
2. Slone Epidemiology Center. Patterns of Medication Use in the United States [on-line]. Available at http://www.bu.edu/slone/SloneSurvey/AnnualRpt/ SloneSurveyWebReport2006.pdf Accessed February 12, 2013.
3. Polinski JM, Schneeweiss S, Levin R, et al. Completeness of retail pharmacy claims data: Implications for pharmacoepidemiologic studies and pharmacy practice in elderly patients. Clin Ther 2009; 31: 2048-2059.
4. Choudhry NK, Fischer MA, Avorn J, et al. The implications of therapeutic complexity on adherence to cardiovascular medications. Arch Intern Med 2011; 171: 814-822.
5. Fleming M, Nemlekar P, Brown CM, et al. Exploratory study of community pharmacists' perceptions about new or transferred prescription incentives. J Am Pharm Assoc (2003) 2012; 52 (5): e53-e58.
6. Zhang Y, Gellad WF, Zhou L, et al. Access to and use of 4 generic programs in medicare. J Gen Intern Med 2012; 27: 1251-1257.
7. Gellad WF, Grenard JL, Marcum ZA,. A systematic review of barriers to medication adherence in the elderly: Looking beyond cost and regiment complexity. Am J Geriatr Pharmacother 2011; 9: 11-23.
8. Donohue JM, Huskamp HA, Wilson IB, et al. Whom do older adults trust most to provide information about prescription drugs? Am J Geriatr Pharmacother 2009; 7: 105-116.
9. Lauffenburger JC, Vu MB, Burkhart JI, et al. Design of a medication therapy management program for Medicare beneficiaries: Qualitative findings from patients and physicians. Am J Geriatr Pharmacother 2012; 10: 129-138.
10. Lau DT, Stubbings J,. Medicare Part D research and policy highlights, 2012: Impact and insights. Clin Ther 2012; 34: 904-914.
11. Institute for Safe Medication Practices. A Call to Action: Protecting U.S. Citizens from Inappropriate Medication Use [on-line]. Available at http://www.ismp.org/pressroom/viewpoints/CommunityPharmacy.pdf Accessed February 12, 2013.
12. Mallet L, Spinewine A, Huang A,. The challenge of managing drug interactions in elderly people. Lancet 2007; 370: 185-191.
13. Pharmacy Quality Alliance, Inc. Medication Adherence Quality Measure #0541 Proportion of Days Covered (PDC): 5 Rates by Therapeutic Category.
14. Yeaw J, Benner JS, Walt JG, et al. Comparing adherence and persistence across 6 chronic medication classes. J Manag Care Pharm 2009; 15: 724-736.
15. Steiner JF,. Rethinking adherence. Ann Intern Med 2012; 157: 580-585.
16. Malone DC, Abarca J, Hansten PD, et al. Identification of serious drug-drug interactions: Results of the partnership to prevent drug-drug interactions. J Am Pharm Assoc 2004; 44: 142-151.
17. Malone DC, Hutchens DS, Haupert H, et al. Assessment of potential drug-drug interactions with a prescription claims database. Am J Health-Syst Pharm 2005; 62: 1983-1991.
18. Simvastatin [package insert]. Whitehouse Station, NJ: Merck & Co., Inc., 2012.
19. Tamblyn RM, McLeod PJ, Abrahamowicz M, et al. Do too many cooks spoil the broth? Multiple physician involvement in medical management of elderly patients and potential inappropriate drug combinations. Can Med Assoc J 1996; 154: 1177-1184.
20. Andersen RM,. Revisiting the behavioral model and access to medical care: Does it matter? J Health Soc Behav 1995; 36: 1-10.
21. The Dartmouth Institute for Health Policy and Clinical Practice. PCSA Data [on-line]. Available at http://pcsa.dartmouth.edu/pcsa-data.php Accessed February 12, 2013.
22. Chronic Condition Data Warehouse User Guide. Version 1.8 [on-line]. Available at https://www.ccwdata.org/cs/groups/public/documents/document/ccw- userguide.pdf Accessed November 19, 2013.
23. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987; 40: 373-383.
24. Imbens GW,. The role of propensity score in estimating dose-response functions. Biometrika 2000; 87: 706-710.
25. Spreeuwenberg MD, Bartak A, Croon MA, et al. The multiple propensity score as control for bias in the comparison of more than two treatment arms: An introduction from a case study in mental health. Med Care 2010; 48: 166-174.
26. Foster EM,. Propensity score matching: An illustrative analysis of dose response. Med Care 2003; 41: 1183-1192.
27. Ratanawongsa N, Karter AJ, Parker MM, et al. Communication and medication refill adherence: The Diabetes Study of Northern California. JAMA Intern Med 2013; 173: 210-218.
28. Juurlink DN, Mamdani M, Kopp A, et al. Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA 2003; 289: 1652-1658.
29. Knijff-Dutmer EA, Schut GA, van de Laar MA,. Concomitant coumarin-NSAID therapy and risk for bleeding. Ann Pharmacother 2003; 37: 12-16.
30. Salanitro AH, Kripalani S,. Prescription refill management and its effect on adherence: comment on "the implications of therapeutic complexity on adherence to cardiovascular medications." Arch Intern Med 2011; 171: 822-823.